drugset / Trial / NCT01860989
A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess efficacy, safety , tolerability and PK in uncomplicated adult malaria patients with acute P. falciparum infection after single dose with KAE609 at 75 mg, 150mg, 225mg and 300mg/day
Timeline
- Start
- 2013-07
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cipargamin | Small molecule | 75 mg | — |
| Subject | cipargamin | Small molecule | 150 mg | — |
| Subject | cipargamin | Small molecule | 225 mg | — |
| Subject | cipargamin | Small molecule | 300 mg | — |
Indications
No indication recorded.